Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA genetic testing of individuals from families with low prevalence of cancer: experiences of carriers and implications for population screening.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Jul 2012

Shkedi-Rafid Shiri, Gabai-Kapara Efrat, Grinshpun-Cohen Julia, Levy-Lahad Ephrat

Abstract excerpt

PURPOSE: BRCA genes are associated with hereditary breast and ovarian cancers. Guidelines worldwide currently recommend BRCA genetic testing in asymptomatic individuals only if they belong to "high-risk" families. However, population screening for BRCA1/2 may be the logical next step in populations with a high prevalence of founder mutations, such as Ashkenazi Jews. This study aimed to explore (i) the impact of a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Attitude to Health
Share to Founder Effect

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Ovarian Neoplasms

Share to Prevalence

Share to Surveys and Questionnaires

Source

Identifiers

PMID: 22481128
DOI: 10.1038/gim.2012.31

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA genetic testing of individuals from families with low prevalence of cancer: experiences of carriers and implications for population screening.PMID 22481128Read ↗

Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.Semantic proximity Read ↗

BRCA awareness and testing experience in the UK Jewish population: a qualitative study.Semantic proximity Read ↗

Experiences from a pilot program bringing BRCA1/2 genetic screening to theUS Ashkenazi Jewish population.Semantic proximity Read ↗

Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experience.Semantic proximity Read ↗

Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening.Semantic proximity Read ↗

Clinicians' attitudes toward general screening of the Ashkenazi-Jewish population for prevalent founder BRCA1/2 and LRRK2 mutations.Semantic proximity Read ↗

Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2.Semantic proximity Read ↗

Attitude towards and factors affecting uptake of population‐based BRCA testing in the Ashkenazi Jewish population: a cohort studySemantic proximity Read ↗

Perceptions of genetic testing for cancer predisposition among Ashkenazi Jewish women.Semantic proximity Read ↗

A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing.Semantic proximity Read ↗

Population-based genetic testing for Women's cancer prevention.Semantic proximity Read ↗

Population-based BRCA1/2 testing programmes are highly acceptable in the Jewish community: results of the JeneScreen Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.